ELEV Live signals | Maximize Profits with Getagraph.com

BUY 134987 min ago

@ $2.71

Issued: 14 Feb 2024 @ 10:56

Return: 33.21%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: -6.62 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States...

Stats
Today's Volume	173 087
Average Volume	963 319
Market Cap	197.24M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $-0.210 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.25
ATR14	$0.0120 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Furlong Tammy	Sell	300	Restricted Stock Unit
2024-05-15	Furlong Tammy	Buy	300	Common Stock
2024-05-15	Furlong Tammy	Sell	100	Common Stock
2024-03-16	Ferra Joseph J Jr	Buy	12 562	Common Stock
2024-03-16	Ferra Joseph J Jr	Sell	4 773	Common Stock

INSIDER POWER
78.22
Last 96 transactions
Buy: 15 873 353 \| Sell: 30 999 346

Volume Correlation

Long: -0.08 (neutral)

Short: 0.38 (neutral)

Signal:(51.179) Neutral

Elevation Oncology, Inc. Correlation

10 Most Positive Correlations
TIOA	0.939
KROS	0.936
MSDA	0.931
CRNT	0.93
ULH	0.924
BRIVU	0.923
MOTNU	0.917
TSCO	0.917
ASLN	0.917
HUGE	0.917

10 Most Negative Correlations
SRNGW	-0.936
RIDE	-0.931
IMBI	-0.927
TCFC	-0.923
FLNC	-0.917
OSTK	-0.916
ENNV	-0.913
EBIX	-0.911
CFRX	-0.91
CARA	-0.909

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Elevation Oncology, Inc. Correlation - Currency/Commodity

-0.47
( neutral )

-0.26
( neutral )

0.00
( neutral )

-0.02
( neutral )

0.17
( neutral )

Elevation Oncology, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2023
Revenue:	$0
Gross Profit:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2022
Revenue:	$0
Gross Profit:	$-27 000.00 (0.00 %)
EPS:	$-4.09

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.386

Financial Reports:

No articles found.

Elevation Oncology, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Elevation Oncology, Inc.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Realtime updates for Elevation Oncology, Inc. [ELEV]

Upcoming Earnings Alert

Elevation Oncology, Inc. Options Data

Calls

Puts